4 November 2026
CVS plans to break itself in two, putting its drugstores in a company of their own
CVS Health says it will separate its roughly 9,000 pharmacies from its insurance and drug-benefits business, creating two public companies by the first half of 2028.
For about two decades CVS has tried to be your pharmacy, your health insurer and the middleman that manages your prescription benefits, all at once. On Wednesday it said it will undo a big part of that. The company plans to split into two separate public companies by the first half of 2028, which CNBC says would rank among the largest corporate breakups ever.
What happened
After what it called a comprehensive strategic review by its board, CVS laid out the new shape:
- CVS Health keeps the name and the insurance side, including Aetna and Caremark, its pharmacy benefit manager. It would also take primary care chain Oak Street Health, home-visit provider Signify Health and the specialty drug business. CEO David Joyner would run it.
- CVS Pharmacy would hold the roughly 9,000 retail stores, led by Prem Shah, currently a group president at CVS Health.
- Current shareholders would end up owning shares of both companies.
The split largely reverses CVS's $78 billion purchase of Aetna in 2018, the deal that made it a vertically integrated giant (one company owning several links in the same supply chain). The Financial Times reported the plan a day earlier.
Why it matters
This is a big company by any measure. Noorult's data shows CVS brought in about $415 billion of revenue over its latest twelve months of filings, with about $4.9 billion of net income, and carries about $61 billion of debt.
The timing is notable because the turnaround seems to be working. Under Joyner, who became CEO in October 2024, CVS has pursued $2 billion of cost cuts, closed stores and worked to control costs in its Medicare Advantage plans. CNBC says the shares are up about 70% since he took over.
Politics is part of the backdrop. Pharmacy benefit managers, or PBMs, negotiate drug prices for insurers and employers, and both parties have criticized them over opaque pricing and conflicts of interest when they also own pharmacies. Congress passed PBM reforms in February, and several states are trying to limit PBMs from owning drugstores. Leerink Partners analyst Michael Cherny called the move a "complete shock" in a note, and suggested that avoiding that state-level scrutiny could be one reason behind it.
It is a rare sight: a company that spent years building a one-stop shop, deciding the shop works better as two.
What to watch
- Names of the rest of the leadership teams and board members, which CVS says will come later.
- How the debt and costs get divided between the two companies.
- Any new federal or state rules on PBM ownership of pharmacies before the 2028 target date.
CVS's full financials are on its Noorult company page.
The companies in this story
Based on reporting by CNBC: CVS to split off drugstore business in major breakup of healthcare giant. Facts, not advice.
More news
- Anthropic's IPO, in numbers: 825 million shares at $70 to $78, and a $1.4 trillion price tag
- Trump says the Nvidia scandal didn't endanger US security, and stands by Lutnick
- Nvidia's first earnings without Huang: what Kress will be asked on Tuesday
- Buffett gives away $5.5 billion of Berkshire stock in his Thanksgiving letter
- Banks are using AI to trim back offices. Proof that it adds revenue is harder to find
- IMF chief says the world economy leans too hard on AI as circular deals top $1 trillion